loader2
Login Open ICICI 3-in-1 Account

Bayer CropScience Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Bayer Cropscience Ltd. 07 Nov 2025 18:07 PM

Q2FY26 Quarterly Result Announced for Bayer Cropscience Ltd.

Agrochemicals company Bayer Cropscience announced Q2FY26 results

  • Revenue from Operations of Rs 15,534 million as compared to Rs 17,382 million in Q2FY25.
  • Profit Before Tax stood at Rs 2,003 million, compared to Rs 1,901 million in Q2FY25.
  • The Board of Directors at its meeting held on November 07, 2025, declared an interim dividend of Rs 90/- per equity share for the financial year ending March 31, 2026, amounting to Rs 4,045 million.

Simon Wiebusch, Vice Chairman & Managing Director & CEO, BCSL, said: “Unusually prolonged and excessive rainfall impacted our field activities and product placement, resulting in significantly lower revenue from our Crop Protection portfolio. Despite this, our corn seed business continued its growth momentum, driven by competitive hybrids, strong execution, and favorable market dynamics. This quarter’s performance underscores our resilience and adaptability in the face of external challenges. We remain focused on preparedness and disciplined execution as we head into the Rabi season.”

Vinit Jindal, Executive Director & Chief Financial Officer, Bayer CropScience, added: “The Company delivered a solid performance with Profit After Tax up 12% in Q2 and 10% in H1 YoY. This was driven by a favorable sales mix, stabilized input costs, lower provisioning for doubtful receivables, and disciplined cost management.”

Result PDF

Agrochemicals company Bayer Cropscience announced Q1FY26 results

  • Revenue from Operations of Rs 19,146 million, compared to Rs 16,314 million in Q1FY25.
  • Profit Before Tax for the quarter stood at Rs 3,352 million, compared to Rs 3,158 million in Q1FY25.

Simon Wiebusch, Vice Chairman & Managing Director & CEO, Bayer CropScience, said: "In Q1, BCSL achieved 17 percent growth in Revenue from Operations, primarily driven by higher volumes of Corn seeds and Roundup® supported by the early onset of the monsoon. Additionally, we successfully launched BICOTA®, an innovation-backed solution for managing Stem Borers in paddy cultivation nationwide to support our smallholder farmers."

Vinit Jindal, Executive Director & Chief Financial Officer, Bayer CropScience, said: “We delivered a 10 percent increase in Profit After Tax for the quarter, underpinned by strong sales growth and early signs of input cost stabilization. While operating expenses were elevated due to the early onset of the monsoon, our continued focus on cost discipline positions us well for sustained performance.”

Result PDF

Agrochemicals company Bayer Cropscience announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • In Q4 of FY 2024-25, the Company registered Revenue from Operations of Rs 10,464 million, compared to Rs 7,923 million in the corresponding quarter of the previous year.
  • Profit Before Tax for the quarter stood at Rs 1,679 million, compared to Rs 1,054 million in the corresponding quarter of the previous year.

FY25 Financial Highlights:

  • In FY 2024-25, the Company’s Revenue from Operations increased to Rs 54,734 million, compared to Rs 51,062 million in the previous year.
  • Profit Before Tax stood at Rs 7,074 million, compared to Rs 9,414 million in the previous year.

Commenting on the quarterly results, Simon Wiebusch, Vice Chairman, Managing Director and CEO, BCSL said, “In Q4, our Revenue from Operations grew by 32 percent over the previous year, driven by strong performance in spring corn and by both strong performance and double-digit liquidation growth in the crop protection portfolio. The promotional investments made in the previous quarter generated significant returns. Quarter-on-quarter deviations reflect the realities of our agriculture. Our focus on liquidation-led channel management aligns with market realities and demonstrates our commitment to delivering continuous value.”

Speaking on the FY results, Vinit Jindal, Executive Director and Chief Financial Officer, BCSL, said, "Our Revenue from Operations grew by 7 percent for the full year, demonstrating our resilience amid challenges like unpredictable monsoons and competitive pressures. Despite strict cost management, higher input costs, provisions for doubtful receivables, and continued investments to expand Bayer’s reach among farmers, influenced our bottom line. Strategic investments drove operating costs. Moving forward, we will maintain focus on these initiatives and adapt our strategies to meet evolving market and stakeholder needs. The Board of Directors has recommended a final dividend payment of Rs 35/- per equity share of Rs 10/- each for the financial year ended March 31, 2025, subject to shareholders’ approval.”

Result PDF

Agrochemicals company Bayer Cropscience announced Q3FY25 results

  • Revenue from Operations of Rs 10,569 million, as compared to Rs 9,549 million in Q3FY24.
  • Profit Before Tax stood at Rs 336 million, compared to Rs 1,242 million in Q3FY24.

Simon Wiebusch, Vice Chairman, Managing Director & Chief Executive Officer, BCSL said: “In Q3, BCSL saw a 11% increase in Revenue from Operations, mainly driven by growth in our Corn business. We prioritized market share gains and launches of new hybrids. Improved reservoir levels compared to last year helped rice cultivation in the South, though growth and profit in our agrochemical business was tempered by reduced investments in the chilli crop. Overall, the current growing season shows good liquidation.”

Simon Britsch, Whole-time Director (Executive) & Chief Financial Officer, BCSL said: “Continuing cost efficiency measures were offset by targeted investments in promotional activities as well as provisions for doubtful receivables, attributable to a challenging agricultural economy. We are actively engaged in recovery efforts.”

Result PDF

Agrochemicals company Bayer Cropscience announced H1FY25 & Q2FY25 results

Q2FY25 Financial Highlights:

  • Revenue from Operations of Rs 17,376 million as compared to Rs 16,172 million in the Q2FY24.
  • Profit Before Tax stood at Rs 1,901 million, compared to Rs 3,057 million in the Q2FY24.

H1FY25 Financial Highlights:

  • Revenue from Operations of Rs 33,688 million compared to Rs 33,568 million for the H1FY24.
  • Profit Before Tax for the H1FY25, stood at Rs 5,059 million, compared to Rs 7,118 million for the H1FY24.

Simon Wiebusch, Vice Chairman & Managing Director and CEO, BCSL said: “In Q2 BCSL achieved a 7% increase in Revenue from Operations primarily driven by higher volumes which were partially offset by price pressure rooted in lower producer prices in China. Moreover, our margins were negatively impacted by higher production costs in corn seeds due to adverse weather conditions as well as a higher cost of goods sold in our chemical business. Despite these headwinds, we are looking forward to a stronger rabi and spring season, delivering sustainable, long-term value for our stakeholders.”

Simon Britsch, Chief Financial Officer, BCSL said: “We maintain our strong focus on cash flow generation and prudent operational expense management. However, we witnessed one-time effects from higher receivables and employee severance provisions. As we look forward, we are confident in our ability to continue with further growth investments and distributing a significant share of our profit to our owners.”

Result PDF

Agrochemicals manufacturer Bayer CropScience announced Q2FY23 results:

  • Q2FY23:
    • Bayer CropScience Limited (BCSL) registered revenue from operations of Rs14,519 million as compared to Rs 13,651 million in the corresponding period of FY21-22.
    • Profit Before Tax stood at Rs 2,290 million, compared to Rs 2,195 million in the corresponding period of the previous financial year.
  • H1FY23:
    • BCSL reported Revenue from operations of Rs 31,193 million, compared to Rs 27,810 million for the corresponding period in FY 2021-22.
    • Profit Before Tax for the H1 that ended on September 30, 2022, stood at Rs 6,113 million, compared to Rs 5,395 million for the corresponding period in FY21-22.

Simon-Thorsten Wiebusch, Executive Director BCSL, said, “Our continuing revenue growth in Q2 was driven largely by strong demand and product liquidation of our crop protection portfolio despite continuing supply chain challenges and a tough hybrid rice season. Supportive commodity prices led to better acreages and strong sales of Corn seeds. A near-normal monsoon in most parts of the country, except Uttar Pradesh, Bihar and West Bengal, also aided positive demand momentum. Our efforts of reaching larger segments of smallholder farmers through alternate go-to-market initiatives such as Sahbhaagi and Better Life Farming Centers are also steadily gaining ground.”

Result PDF

Agrochemicals company Bayer Cropscience announced Q1FY23 results:

  • Revenue from Operations of Rs 16,674 million
  • Profit Before Tax of Rs 3,823 million

Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “Our Q1 revenue from operations registered a robust growth of 18% despite global supply chain constraints. This was driven largely by our crop protection portfolio and product liquidation. We also witnessed volume growth in Corn seeds, driven by portfolio growth and better acreages in Kharif. Our rice hybrid volumes were impacted due to a delay in monsoon and unfavorable market conditions. Going forward, we expect challenges to persist specifically around global supplies of RoundUp® in the near term. However, we will continue proactive efforts to drive future growth with our diversity of portfolio and alternate business models.”

 

Result PDF

Agrochemicals firm Bayer Cropscience declares Q4FY22 result:

  • FY 2021-22: Revenue from Operations of  Rs 47,344 million and Profit Before Exceptional Items & Tax of Rs 7,883 million
  • Q4 2021-22: Revenue from Operations of Rs 9,633 million and Profit Before Exceptional Items & Tax of Rs 1,895 million
  • Revenue from Operations of Rs 47,344 million, compared to Rs 42,613 million in the previous year, registering an overall revenue growth of 11%. Profit Before Exceptional Items & Tax stood at Rs 7,883 million, compared to Rs 7,894 million in the previous year. Profit after Exceptional Items & Tax increased by 31% from Rs 4,931 million to  Rs 6,453 million.
  • In Q4 of FY 2021-22, the Company registered Revenue from Operations of Rs 9,633 million, compared to Rs 7,337 million in the corresponding quarter of the previous year, delivering a strong growth of 31%. Profit Before Exceptional Items & Tax for the quarter stood at Rs 1,895 million, compared to Rs 735 million in the corresponding quarter of the previous year.

Commenting on the quarterly results, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Limited said, “New product launches such as Vayego and Dekalb 9208 and overall strong crop sentiments were key drivers for our sales growth in Q4. This has been achieved overcoming some supply constraints faced during the quarter and partially offsetting inflationary pressure with price increases.”

Speaking on the FY results, Simon Britsch, Chief Financial Officer, Bayer CropScience Limited said, “Effective demand generation, scaling up of alternate business models and new product launches, enabled us to post strong growth of 11% in Revenue from Operations. Our operating costs increases were driven by our continuing investments into strategic initiatives to expand Bayer’s farmer reach of our portfolio and normalization of business activities as travel restrictions eased. During the year, the Company had an exceptional income of Rs 585 million arising from the sale of part of the seed distribution business viz. mustard, cotton, millet and sorghum seeds. The Board of Directors has recommended a final dividend payment of Rs 25/- per equity share of Rs 10/- each for the financial year ended March 31, 2022, subject to shareholders’ approval.”

Result PDF

Agrochemicals company Bayer Cropscience declares Q3FY22 result:

  • Revenue from Operations of Rs 9,901 million
  • Profit Before Exceptional Items and Tax of Rs 593 million
  • Profit Before Tax (After Exceptional Items) of Rs 1,178 million
  • In the third quarter (Q3) of Financial Year (FY) 2021-22, Bayer CropScience Limited (BCSL) earned Revenue from Operations of Rs 9,901 million, as compared to Rs 9,182 million in the corresponding period of FY 2020-21.
  • Profit Before Exceptional Items and Tax stood at Rs 593 million, compared to Rs 1,061 million in the corresponding period of FY 2020-21.
  • Profit Before Tax (After Exceptional Items) stood at Rs 1,178 million as compared to Rs 1,061 million in the corresponding period of FY 2020-21.
  • For the nine months ended December 31, 2021, BCSL reported Revenue from Operations of Rs 37,711 million, compared to Rs 35,276 million for the corresponding period in FY 2020-21.
  • Profit Before Exceptional Items and Tax for the nine months ended December 31, 2021 stood at Rs 5,988 million, compared to Rs 7,159 million for the corresponding period in FY 2020-21.
  • Profit Before Tax (After Exceptional Items) stood at Rs 6,573 million as compared to Rs 7,147 million in the corresponding period of FY 2020-21.

Commenting on the company’s performance, Simon-Thorsten Wiebusch, Executive Director, Bayer CropScience Ltd. said, “Our Q3 revenue from operations has registered an 8% growth over the same period last year despite unseasonal rains, crop infestations and a challenging rabi corn season. Growth was largely driven by our Crop Protection portfolio that witnessed a surge in demand with double-digit liquidation growth sustained by our strategy of prudent channel management and demand generation. Overall profitability was impacted by higher input and operational costs which included building out new business models for increasing market reach to smallholders, corn seed returns and obsolescence effects, offset by the exceptional income arising from the sale of the business of mustard, cotton, millet and sorghum seeds.”

He further stated, “Enhancing real-time agronomy advisory, farm collectivization efforts and driving market linkages through Farmer Producer Organizations (FPOs) and digitalization are important drivers to transform Indian agriculture. Bayer stands committed to maximize its efforts to benefit smallholder farmers, expand the base of its Better Life Farming centers, create gender smart interventions, double down on its sustainability efforts and make Indian agriculture competitive.”

Result PDF

Highlights for Q2 ended September 30, 2021:

  • Revenue from Operations was Rs.13,651 million as compared to Rs. 13,816 million in the corresponding period of FY 2020- 21
  • Profit Before Exceptional Items and Tax stood at Rs. 2,195 million, compared to Rs. 2,960 million in the corresponding period of the previous financial year. 
  • For the H1 ended September 30, 2021, BCSL reported Revenue from Operations of Rs. 27,810 million compared to Rs. 26,094 million for the corresponding period in FY 2020-21.
  • Profit Before Exceptional Items and Tax for the H1 ended September 30, 2021 stood at Rs. 5,395 million, compared to Rs. 6,098 million for the corresponding period in FY 2020-21

Speaking about the financial results, D. Narain, CEO & Managing Director of Bayer CropScience Limited, said, “Our half-yearly revenue growth of 7% was primarily driven by Crop Protection products including the herbicide Roundup and new product launches while our second quarter revenue declined by 1% compared to last year. Overall profitability was impacted by a challenging season for our Corn Seeds portfolio and pressure on margins in our Crop Protection business. The Kharif Corn season witnessed a drop in acreages owing to lower relative profitability of Corn for the grower versus other crops, as well as some weather-related events leading to higher seeds returns in the second quarter. Crop Protection business was impacted by higher material & logistics costs and product mix, partially offset by product price increases. Given unseasonal rains and subsequent slowing of liquidation in late September, we consciously reduced our channel placements.”

D. Narain added, “We will continue to focus our investments on capacity building programs for smallholder farmers in India, especially through the continuing expansion of the Better Life Farming program and new business models such as eCommerce and Food Chain Partnerships. With drones now being available for agriculture, we look forward to accelerating innovations that foster precision farming, resource efficiencies and sustainability.” 

 

 

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app